AzTrials
AzTrials

Blood Pressure, HighNCT05851040

Observe the Effect of Wheatgrass and Tulsi Formulation or Individuals Taken With Other Allopathic Drugs

An observational study of Blood Pressure, High and Blood Sugar; High, run by Swalife Biotech at 1 site in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Antioxidant qualities have been attributed to wheatgrass and tulsi formulation. Free radicals are unstable molecules created by the body during metabolism and exposure to environmental pollutants. Antioxidants are chemicals that can help stop or reduce cell damage caused by these unstable molecules. Read more about this study

Who is it for?
Ages 30 to 75 years
What is being tested?
Observation study
How many people
100 participants
Where
1 siteIndia
Study dates
10 May 2023to 30 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The population of age group 30 to 65 is targeted who have chronic disease and are taking wheat grass and tulsi formulation.

Who may be able to join

  • Patients who are having a chronic disease and taking formulation wheat grass and tulsi.
  • Patients who are taking wheatgrass and tulsi separately.
  • Patients who are taking wheatgrass, tulsi and regular medicine. -

Who cannot join

  • Patients below 30 years.
  • Patients who are having a chronic disease but not using formulations of wheatgrass and tulsi.
  • Patients who are not taking wheatgrass and tulsi separately.

Trial locations and contacts

1 site in 1 country.

India1 site
  • Sinhgad college of Pharmacy

    Pune, Maharashtra, 411041

    Pravin Badhe, PhD, 7038248513 ext. 91, drpravinbadhe@swalifebiotech.com

    Pravin Badhe, PhD

Other trials in India

About this study

Official title: Observation of Wheatgrass and Tulsi Formulation or Its Effect With Allopathic Drugs

Antioxidant qualities have been attributed to wheatgrass and tulsi formulation. Free radicals are unstable molecules created by the body during metabolism and exposure to environmental pollutants. Antioxidants are chemicals that can help stop or reduce cell damage caused by these unstable molecules. Oxidative stress, which is brought on by free radicals, has been connected to a number of health issues, including chronic inflammation, cardiovascular disease, cancer, and ageing. Wheatgrass is a rich source of vitamins, minerals, amino acids, and chlorophyll, which have been shown to have antioxidant and anti-inflammatory effects. Tulsi, also known as holy basil, is an herb that has been used in Ayurvedic medicine for centuries and has been found to have antioxidant, anti-inflammatory, and immunomodulatory properties. Several studies have investigated the antioxidant properties of wheatgrass and tulsi formulation. For instance, a study published in the Journal of Food Science and Technology in 2015 found that wheatgrass extract had significant antioxidant activity, as measured by its ability to scavenge free radicals and reduce lipid peroxidation in vitro.

Read the detailed description

Similarly, a study published in the Journal of Ethnopharmacology in 2001 found that tulsi extract had significant antioxidant activity, as measured by its ability to scavenge free radicals and inhibit lipid peroxidation in vitro. Moreover, a study published in the Journal of Medicinal Food in 2011 investigated the antioxidant and anti-inflammatory effects of a combination of wheatgrass and tulsi extracts in rats. The study found that the combination of wheatgrass and tulsi extracts had significant antioxidant and anti-inflammatory effects, as measured by reductions in oxidative stress markers and pro-inflammatory cytokines. Overall, the available evidence suggests that wheatgrass and tulsi formulations may have antioxidant properties, which could potentially help prevent or slow down oxidative stress-related health problems. However, more research is needed to confirm these findings and determine the optimal dosage and duration of wheatgrass and tulsi formulation use for maximum antioxidant benefits. There are several studies that suggest wheatgrass and tulsi formulations have antioxidant properties. A study evaluated the immunomodulatory and antioxidant properties of a traditional formulation containing Tulsi, ginger, and wheatgrass. Another study investigated the antioxidant potential of anthocyanin extracts from colored wheat flour and wheat-grass juice. Additionally, a synergistic effect of conventional medicinal herbs against oxidative stress was observed in another study that included tulsi and wheatgrass. While a study compared the chemical composition, sensory, phenolic, and antioxidant properties of juices from different wheatgrass and turfgrass species, it did not specifically investigate a formulation with tulsi. Another study found that vitamin C is present in wheatgrass which is also an antioxidant.

Being tested
Observation study
Medical subject headings
Hypertension, Hyperglycemia, Birth Weight, Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Observation studyOther

    Looking to find the role of wheatgrass and tulsi give separately or with allopathic drug

Study groups in NCT05851040
Study groupRoleWhat they receive
With Wheatgrass, tulsi formulationPeople using Wheatgrass and Tulsi formulation or individual
Receives: Other: Observation study
With Wheatgrass, tulsi formulation and allopathic drugsPeople using Wheatgrass and Tulsi formulations or individuals with chronic disease medicine.
Receives: Other: Observation study
Same age group not using any medicationNot described
Receives: Other: Observation study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effect of wheat grass and tulsi in combination on blood pressure

    Blood Pressure measured in mmHg every four week.

    Measured: Every four week till 6 months

  2. Effect of wheat grass and tulsi in combination on blood sugar

    Blood Sugar measured in mmol/L every four week

    Measured: Every four week till 6 months

  3. Effect of wheat grass and tulsi in combination on weight

    Weight is measure in Kg every four week.

    Measured: Every four week till 6 months

  4. Effect of wheat grass and tulsi in combination on smoking

    questionnaire assesment for "Smoking habits"

    Measured: Every four week till 6 months

Secondary outcomes (8)
  1. Effect of wheat grass and tulsi separately on blood pressure

    Blood Pressure measured in mmHg every four week.

    Measured: Every four week till 6 months

  2. Effect of wheat grass and tulsi separately on blood sugar

    Blood Sugar measured in mmol/L every four week.

    Measured: Every four week till 6 months

  3. Effect of wheat grass and tulsi separately on weight

    Weight is measure in Kg every four week.

    Measured: Every four week till 6 months

  4. Effect of wheat grass and tulsi separately on smoking

    questionnaire assesment for "Smoking habits"

    Measured: Every four week till 6 months

  5. Effect of wheat grass, tulsi and allopathic drug on blood pressure

    Blood Pressure measured in mmHg every four week.

    Measured: Every four week till 6 months

  6. Effect of wheat grass, tulsi and allopathic drug on blood sugar

    Blood Sugar measured in mmol/L every four week.

    Measured: Every four week till 6 months

  7. Effect of wheat grass, tulsi and allopathic drug on weight

    Weight is measure in Kg every four week.

    Measured: Every four week till 6 months

  8. Effect of wheat grass, tulsi and allopathic drug on smoking

    questionnaire assesment for "Smoking habits"

    Measured: Every four week till 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2023
  2. Study start10 May 2023 (estimated)
  3. Primary completion30 Oct 2023 (estimated)
  4. Study completion30 Oct 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05851040
Sponsor's protocol ID
swalife001
Status last verified
May 2023
First submitted
25 Apr 2023
Last updated
9 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: We will be sharing the Protocol of the study and the execution.

Questions about this trial

What is this clinical trial studying?

An observational study of Blood Pressure, High and Blood Sugar; High, run by Swalife Biotech at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pravin Badhe, PhD (7038248513 ext. 91, drpravinbadhe@swalifebiotech.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effect of wheat grass and tulsi in combination on blood pressure (time frame: Every four week till 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in